EUROPE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Lifesciences | Healthcare & Wellness

EUROPE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Market by Drug Class, Application, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on the European dermatological therapeutics market depicts that it will grow at a CAGR of 7.92% in terms of revenue during the forecast period 2019-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market include:

•           The United Kingdom

•           France

•           Spain

•           Italy

•           Germany

•           Russia

•           Rest of Europe countries

A recent study by Michael J Cork establishes that there is a high prevalence of atopic dermatitis in the United Kingdom. Around 5–10% of adults and 11–20% of children are said to be affected by this condition. Also, 2% of all the affected children fall under the category of severe cases.

Similarly, according to a 2018 study on the epidemiology of rosacea in the country, the overall rate of incidence of diagnosed rosacea was 1·65 per 1000 person-years. Approximately 80% of the people aged over 30 years were diagnosed with this skin condition. Thus, the growing prevalence of skin diseases in the UK has accelerated the demand for dermatological therapy. This is boosting the growth of the nation’s dermatological therapeutics market.

Furthermore, several organizations in the UK are working to spread awareness about skin diseases in the country. For instance, the British Association of Dermatologists (BAD) has launched Sun Awareness, which is a national-level campaign to educate people about skin cancer. The enhanced public awareness, as a result of these initiatives to educate them, has proven effective in raising the demand for dermatological therapeutics in the United Kingdom. This increased demand spells positive growth for the UK market in the years to come.

Almirall is a leading pharmaceutical company focusing on skin health. Its products are used to treat dermatological conditions like atopic dermatitis, actinic keratosis, inflammatory skin conditions, eczema, rosacea, psoriasis, and severe acne, among others. Some of its well-known products include Aczone, Actikerall, Balneum Hermal F, and Betalfarus. Founded in 1943, it is headquartered in Barcelona, Spain. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   ADVANCEMENTS IN BIOLOGICS

2.2.2.   ATOPIC DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF SUPPLIERS

2.3.4.   BARGAINING POWER OF BUYERS

2.3.5.   THREAT OF COMPETITIVE RIVALRY

2.4. IMPACT OF COVID-19 – DERMATOLOGICAL THERAPEUTICS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. MARKET DRIVERS

2.7.1.   INCREASING BURDEN OF DERMATOLOGICAL DISEASES

2.8. MARKET RESTRAINTS

2.8.1.   GRAVE SIDE-EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS

2.9. MARKET OPPORTUNITIES

2.9.1.   RISE IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION

2.10. MARKET CHALLENGES

2.10.1.  UNAWARENESS REGARDING DERMATOLOGICAL DIAGNOSIS

3. EUROPE DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS

3.1. ANTI-INFECTIVES

3.2. CORTICOSTEROIDS

3.3. ANTI-ACNE

3.4. CALCINEURIN INHIBITORS

3.5. RETINOIDS

3.6. OTHER DRUG CLASSES

4. EUROPE DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION

4.1. ALOPECIA

4.2. HERPES

4.3. PSORIASIS

4.4. ROSACEA

4.5. ATOPIC DERMATITIS

4.6. ACNE VULGARIS

4.7. OTHER APPLICATIONS

5. EUROPE DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK

5.1. EUROPE

5.1.1.   UNITED KINGDOM

5.1.2.   GERMANY

5.1.3.   FRANCE

5.1.4.   SPAIN

5.1.5.   ITALY

5.1.6.   RUSSIA

5.1.7.   REST OF EUROPE

6. COMPETITIVE LANDSCAPE

6.1. ABBVIE INC

6.2. ALLERGAN

6.3. ALMIRALL

6.4. AMGEN INC

6.5. BAUSCH HEALTH COMPANIES INC

6.6. GALDERMA

6.7. GLAXOSMITHKLINE PLC

6.8. JOHNSON & JOHNSON

6.9. NOVARTIS AG

6.10. PFIZER INC

6.11. AGI DERMATICS

6.12. LEO PHARMA A/S

6.13. MERCK & CO

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of table

TABLE 1: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 5: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 6: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 3: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 4: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 5: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 6: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 7: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 8: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 9: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 10: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 11: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 12: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)

FIGURE 13: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 14: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 15: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 16: UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 17: GERMANY DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 18: FRANCE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 19: SPAIN DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 20: ITALY DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 21: RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 22: REST OF EUROPE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;